Natixis Advisors LLC Makes New Investment in First Advantage Co. (NYSE:FA)

Natixis Advisors LLC acquired a new position in First Advantage Co. (NYSE:FA) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 15,036 shares of the company’s stock, valued at approximately $298,000.

Several other hedge funds also recently bought and sold shares of FA. Quarry LP lifted its position in First Advantage by 49.7% during the second quarter. Quarry LP now owns 2,607 shares of the company’s stock valued at $42,000 after purchasing an additional 865 shares during the last quarter. Marshall Wace LLP purchased a new stake in shares of First Advantage during the second quarter worth about $209,000. Oppenheimer Asset Management Inc. acquired a new position in shares of First Advantage during the second quarter valued at about $211,000. Truist Financial Corp purchased a new position in shares of First Advantage in the 2nd quarter valued at approximately $234,000. Finally, Price T Rowe Associates Inc. MD boosted its stake in First Advantage by 16.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,478 shares of the company’s stock worth $252,000 after purchasing an additional 2,163 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on FA. Wolfe Research downgraded First Advantage from an “outperform” rating to a “peer perform” rating in a research note on Thursday, October 10th. Citigroup lifted their target price on First Advantage from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, September 25th. Royal Bank of Canada started coverage on First Advantage in a research note on Friday, November 15th. They issued an “outperform” rating and a $22.00 price target on the stock. Barclays reiterated an “overweight” rating and set a $22.00 target price on shares of First Advantage in a research note on Wednesday, November 20th. Finally, William Blair reiterated an “outperform” rating on shares of First Advantage in a research report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, First Advantage currently has a consensus rating of “Moderate Buy” and an average price target of $58.83.

First Advantage Trading Down 2.3 %

Shares of First Advantage stock opened at $19.28 on Friday. The business’s fifty day moving average is $18.98 and its two-hundred day moving average is $17.76. First Advantage Co. has a fifty-two week low of $13.88 and a fifty-two week high of $20.79. The company has a quick ratio of 3.85, a current ratio of 3.85 and a debt-to-equity ratio of 0.61. The firm has a market cap of $3.33 billion, a PE ratio of 642.67 and a beta of 1.18.

First Advantage (NYSE:FA) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.01. First Advantage had a return on equity of 13.16% and a net margin of 0.65%. The firm had revenue of $199.10 million for the quarter, compared to analysts’ expectations of $204.39 million. During the same quarter in the prior year, the firm posted $0.25 earnings per share. First Advantage’s revenue for the quarter was down .6% compared to the same quarter last year. Analysts anticipate that First Advantage Co. will post 0.75 earnings per share for the current year.

First Advantage Profile

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.